M
Mediwound Ltd (MDWD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$13.55
+0.65 (+5.04%)
Market Cap: $185.63M
Last updated: Nov 17, 2026 at 11:04 AM ET
Mediwound Ltd (MDWD) Valuation Multiples
Mediwound (MDWD) trades at 17.6x sales and 5.6x book value. Its P/S of 17.6x is above its 5-year median of 7.3x. Its forward P/E is 35.0x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 35.0x |
| Price to sales | 17.6x |
| Price to book | 5.6x |
| PEG | N/A |
| FCF yield | -18.4% |
Historical Medians
Against its 10-year medians, its P/S is 122.8% above 7.9x and its P/B is 27.3% below 7.7x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 17.6x | 7.3x | 7.9x |
| P/B | 5.6x | 5.3x | 7.7x |
Valuation History
Over the 10 year ends shown, its P/S ranged from 2.6x in 2022 to 64.2x in 2016.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $18.46 | N/A | 12.1x | 5.4x |
| 2024 | $17.80 | N/A | 8.7x | 6.2x |
| 2023 | $10.17 | N/A | 4.9x | 3.0x |
| 2022 | $13.49 | N/A | 2.6x | 7.8x |
| 2021 | $16.52 | N/A | 2.7x | N/A |
| 2020 | $25.89 | N/A | 4.6x | 13.8x |
| 2019 | $21.69 | 38.7x | 2.6x | 5.6x |
| 2018 | $28.41 | N/A | 32.4x | 12.3x |
| 2017 | $31.14 | N/A | 41.0x | 12.5x |
| 2016 | $32.04 | N/A | 64.2x | 12.9x |
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About MDWD
What is MDWD's forward P/E ratio?
Mediwound has a forward P/E ratio of 35.0x.
Is MDWD stock overvalued?
GNG's valuation label for MDWD is Overvalued.
What is MDWD's price to sales ratio?
Mediwound has a price to sales ratio of 17.6x.
MDWD pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts